Shilan Mozaffari

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 9

Top Topics

Clostridium Difficile

Health Information

Irritable Bowel Syndrome

Top Venues

Expert opinion on investigational drugs

Expert opinion on drug metabolism & toxicology

This page only lists publications with an associated author ORCID identifier.

Publications

Shilan Mozaffari, Shekoufeh Nikfar, Mohammad Abdollahi
Drugs of the future for diarrhea-predominant irritable bowel syndrome: an overview of current investigational drugs. Expert opinion on investigational drugs (2024)
Shilan Mozaffari, Shekoufeh Nikfar, Mohammad Abdollahi
Pharmacokinetic considerations for drugs that treat diarrhea-predominant irritable bowel syndrome: what's new? Expert opinion on drug metabolism & toxicology (2024)
Shilan Mozaffari, Shekoufeh Nikfar, Mohammad Abdollahi
Drugs of the future for diarrhea-predominant irritable bowel syndrome: an overview of current investigational drugs. Expert opinion on investigational drugs (2024)
Shilan Mozaffari, Shekoufeh Nikfar, Mohammad Abdollahi
Pharmacokinetic considerations for drugs that treat diarrhea-predominant irritable bowel syndrome: what's new? Expert opinion on drug metabolism & toxicology 20 (5) (2024)
Shilan Mozaffari, Shekoufeh Nikfar, Mohammad Abdollahi
Drugs of the future for diarrhea-predominant irritable bowel syndrome: an overview of current investigational drugs. Expert opinion on investigational drugs 33 (3) (2024)
Shilan Mozaffari, Shekoufeh Nikfar, Mohammad Abdollahi
Drugs of the future for diarrhea-predominant irritable bowel syndrome: an overview of current investigational drugs. Expert opinion on investigational drugs 33 (3) (2024)
Shilan Mozaffari, Shekoufeh Nikfar, Mohammad Abdollahi
Pharmacokinetic considerations for drugs that treat diarrhea-predominant irritable bowel syndrome: what's new? Expert opinion on drug metabolism & toxicology 20 (5) (2024)
Shilan Mozaffari, Shekoufeh Nikfar, Mohammad Abdollahi
Drugs of the future for diarrhea-predominant irritable bowel syndrome: an overview of current investigational drugs. Expert opinion on investigational drugs 33 (3) (2024)
Shilan Mozaffari, Taraneh Mousavi, Shekoufeh Nikfar, Mohammad Abdollahi
Common gastrointestinal drug-drug interactions in geriatrics and the importance of careful planning. Expert opinion on drug metabolism & toxicology (2023)